Biomedical technologies are relatively new and simultaneously one of the most extensive interdisciplinary fields of modern science and is characterised by an enormous potential for development. Combining the achievements of biological, biochemical and biophysical sciences with the achievements of the contemporary technology, including information technology, brings about extremely fascinating results of the research works conducted in this aspect: starting from production of antibodies, vaccines, tumour markers or new targeted drugs, precisely supplied by biological or chemical carriers to specific locations in the organism, through tissue engineering allowing for replacing, restoring, improving or sustaining functions of damaged tissues or organs by means of biological implants or cell transplants, and ending up with genetic engineering and gene therapies. The conference is dedicated to the evaluation of the state, trends, factors and implications regarding further development of the biomedical technology. The conference co-organisers include: the Medical University of Łódź, Ardigen S.A., Małopolska Center of Technology Jagiellonian University and the Translational Medicine Centre of Warsaw University of Life Sciences.
SESSION 1
09.00 – 11.00
Reshaping the Future of Biomedical Engineering
CHAIRPERSON
Vice Rector for Research Strategy and International Relations, Head of the Department of Structural Biology at the Medical University of Lodz, Member of the Supervisory Board and Strategic Innovation Council of EIT HEALTH, Member of the Supervisory Board of EIT HEALTH Innostars, Chair of the Scientific Advisory Board (Life Sciences) of Vrije Universitet in Brussels (Belgium)
SPEAKERS
SESSION 2
11.15 – 13.15
INNOVATIVE APPROACH TO PHENOTYPIC DRUG DISCOVERY
11.15 – 11.20
Welcome guests start of the session
11.20 – 11.35
KEYNOTE
General introduction to the session theme
11.35 – 12.25
Three keynote presentations:
11.35 – 11.50
“MetaSUB – from city microbiome exploratory study to improved citizens’ health and well-being”
11.50 – 12.05
“The Skin Microbiome: from Lab to Treatment”
12.05 – 12.25
“With image and structure. Using AI and multiple data sources to enhance drug discovery process”
12.25 – 13.15
Topical panel discussion :
„How to make phenotypic drug discovery more efficient through academia-industry collaboration?”
Leading the discussion:
Panelists:
12.45 – 14.00
LUNCH BREAK
SESSION 3
14.00 – 15.30
FROM ANIMAL TO HUMAN – IMPORTANCE OF ANIMAL MODELS IN BIOMEDICAL RESEARCH
14.00 – 14.05
Welcome guests start of the session and general introduction to the session
14.05 – 14.25
KEYNOTE
“Confirmation of non-clinical studies in patients with malignant brain tumors and Parkinson’s disease”
14.25 – 14.50
“The use of advanced imaging to model brain diseases and guide therapy”
14.50 – 15.30
Topical panel discussion :
“From Animal to Human – Importance of Animal Models in Biomedical Research”
Leading the discussion:
Participants:
15.30 – 16.00
CLOSING SESSION
Chair – dr. Zygmunt Krasiński, president of the Polish Chamber of Commerce for High Technology